A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis

NCT00131300 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Osteoarthritis
Musculoskeletal Diseases

Interventions

DEVICE: Synvisc (hylan G-F 20)

Sponsor

Genzyme, a Sanofi Company